Plasma Cell precursor and Other Disorders
A retrospective analysis of the efficacy and safety of a single-center daltuzumab-based treatment for light chain amyloidosis
Wang xinran
1095 Jie-Fang Avenue, Wuhan, Hubei, 430030, P. R. China.
Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, China (People's Republic)